FDA Advisory Panel Agrees Pulse Oximeter Skin Pigment Discrepancies Pose Clinical Threat

The FDA’s Anesthesiology and Respiratory Therapy Devices advisory panel met to discuss racial and skin-pigmentation bias in pulse oximeter devices as well as recommendations for the agency.